{
  "id": "60314ce01cb411341a00012f",
  "type": "list",
  "question": "Please list the syndromes that are part of Castleman's disease AKA TAFRO",
  "ideal_answer": "The syndromes that are part of Castleman's disease AKA TAFRO are:1) organomegaly, 2) anasarca, 3) myelofibrosis, 4) thrombocytopenia and 5) reticulin fibrosis.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28580156",
    "http://www.ncbi.nlm.nih.gov/pubmed/33014503",
    "http://www.ncbi.nlm.nih.gov/pubmed/29157612",
    "http://www.ncbi.nlm.nih.gov/pubmed/32775816",
    "http://www.ncbi.nlm.nih.gov/pubmed/31211492",
    "http://www.ncbi.nlm.nih.gov/pubmed/33269653",
    "http://www.ncbi.nlm.nih.gov/pubmed/29468524",
    "http://www.ncbi.nlm.nih.gov/pubmed/23801135",
    "http://www.ncbi.nlm.nih.gov/pubmed/27316721",
    "http://www.ncbi.nlm.nih.gov/pubmed/23801138",
    "http://www.ncbi.nlm.nih.gov/pubmed/26250536",
    "http://www.ncbi.nlm.nih.gov/pubmed/30244358",
    "http://www.ncbi.nlm.nih.gov/pubmed/25671135",
    "http://www.ncbi.nlm.nih.gov/pubmed/31579342",
    "http://www.ncbi.nlm.nih.gov/pubmed/26886414",
    "http://www.ncbi.nlm.nih.gov/pubmed/27516889",
    "http://www.ncbi.nlm.nih.gov/pubmed/31222819",
    "http://www.ncbi.nlm.nih.gov/pubmed/26805758",
    "http://www.ncbi.nlm.nih.gov/pubmed/31631463",
    "http://www.ncbi.nlm.nih.gov/pubmed/26781021",
    "http://www.ncbi.nlm.nih.gov/pubmed/30009125",
    "http://www.ncbi.nlm.nih.gov/pubmed/27725549",
    "http://www.ncbi.nlm.nih.gov/pubmed/32492687"
  ],
  "snippets": [
    {
      "text": ": Although thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly (TAFRO) syndrome was first described as a variant of idiopathic multicentric Castleman disease (CD), patients with TAFRO syndrome demonstrate more aggressive clinical features.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31211492",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly (TAFRO) syndrome is a severe subtype of idiopathic multicentric Castleman's disease, characterized by thrombocytopenia, anasarca, fever, reticulin myelofibrosis, and organomegaly. Renal complication of this disease can be life-threatening and sometimes requires hemodialysis, but it has not been elucidated in detail.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32775816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TAFRO syndrome (thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly) is an atypical manifestation of multicentric Castleman's disease. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30244358",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23801135",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "BACKGROUND: Castleman-Kojima disease (TAFRO Syndrome) is characterized by Thrombocytopenia, Anasarca, myeloFibrosis, Renal dysfunction, Organomegaly, multiple lymphadenopathy and histopathology pattern of atypical Castleman's disease (CD).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25671135",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A unique clinicopathologic variant of multicentric Castleman's disease, TAFRO (i.e., thrombocytopenia, anasarca, fever, renal failure or reticulin fibrosis, and organomegaly) syndrome, was recently proposed in Japan.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26250536",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TAFRO syndrome is a novel disease concept characterized by Thrombocytopenia, Anasarca, myeloFibrosis, Renal dysfunction, Organomegaly, multiple lymphadenopathy and a histopathological pattern of atypical Castleman's disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31579342",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thrombocytopenia (T), anasarca (A), myelofibrosis (F), renal dysfunction (R), and organomegaly (O) (TAFRO) syndrome is a variant of multicentric Castleman's disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27516889",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Introduction: Thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly (TAFRO) syndrome is a severe subtype of idiopathic multicentric Castleman's disease, characterized by thrombocytopenia, anasarca, fever, reticulin myelofibrosis, and organomegaly.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32775816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recently, a unique clinicopathologic variant of multicentric Castleman disease, TAFRO (i.e. thrombocytopenia, anasarca, fever, renal failure or reticulin fibrosis and organomegaly) syndrome, has been identified in Japan. Previo",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33269653",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Although thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly (TAFRO) syndrome was first described as a variant of idiopathic multicentric Castleman disease (CD), patients with TAFRO syndrome demonstrate more aggressive clinical fea",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31211492",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thrombocytopenia, anasarca, fever, reticulin fibrosis, organomegaly (TAFRO) syndrome is a unique clinicopathologic subtype of multicentric Castleman's disease that has recently been identified in Japan. Howev",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29468524",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome is a unique clinicopathologic variant of multicentric Castleman's disease that has recently been identified in Japan. Previ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26781021",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TAFRO syndrome is a newly recognized variant of idiopathic multicentric Castleman disease (iMCD) that involves a constellation of syndromes: thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O). Thromboc",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29157612",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thrombocytopenia, anasarca, myelofibrosis, renal dysfunction and organomegaly (TAFRO) syndrome is a variant of Castleman's disease recently identified in Japan. A 73",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27725549",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thrombocytopenia, anasarca, fever, renal insufficiency, and organomegaly constitute TAFRO syndrome, a variant of Castleman disease. We ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30009125",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome is considered as a unique clinicopathologic variant of multicentric Castleman's disease and is recently reported in Japan. This ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26886414",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: Thrombocytopenia, ascites, myelofibrosis, renal dysfunction, and organomegaly (TAFRO) syndrome is a newly recognized and rare clinical subtype of Castleman",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32492687",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The pathophysiology and comorbidities of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly), which is thought to be a variant of multicentric Castleman's disease, are not fully understood, and there are few data on the effectiveness of treatments.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33014503",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome is considered as a unique clinicopathologic variant of multicentric Castleman's disease and is recently reported in Japan.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26886414",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thrombocytopenia, anasarca, fever, reticulin fibrosis, organomegaly (TAFRO) syndrome is a unique clinicopathologic subtype of multicentric Castleman's disease that has recently been identified in Japan.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29468524",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome is a unique clinicopathologic variant of multicentric Castleman's disease that has recently been identified in Japan.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26781021",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: Thrombocytopenia, ascites, myelofibrosis, renal dysfunction, and organomegaly (TAFRO) syndrome is a newly recognized and rare clinical subtype of Castleman disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32492687",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TAFRO represents the constellation of symptoms (Thrombocytopenia, Anasarca, MyeloFibrosis, Renal failure, Organomegaly).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28580156",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TAFRO syndrome is a newly recognized variant of idiopathic multicentric Castleman disease (iMCD) that involves a constellation of syndromes: thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29157612",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TAFRO syndrome is a newly identified disorder of unknown etiology characterized by thrombocytopenia, anasarca, fever, reticulin myelofibrosis, renal dysfunction, and organomegaly.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31222819",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recently, a new variant of the disease was reported and named TAFRO syndrome, an acronym for thrombocytopenia, ascites, myelofibrosis, renal dysfunction, and organomegaly.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27316721",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recently, a limited series of iMCD cases in Japan sharing a constellation of clinical features, including thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O) has been described as TAFRO syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26805758",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "reported a new disease concept, TAFRO syndrome, named from thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23801138",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Castleman-Kojima disease, also known as idiopathic multicentric Castleman disease with TAFRO syndrome (iMCD-TAFRO), is a recently recognized systemic inflammatory disorder with a characteristic series of clinical symptoms, including thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31631463",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, reticulin fibrosis, organomegaly"
}